Table 2 Comparison of crude outcomes between the two groups
From: Effect of tranexamic acid on mortality in patients with haemoptysis: a nationwide study
Control (n = 11,490) | Tranexamic acid (n = 17,049) | p value | |
|---|---|---|---|
Primary outcome | |||
In-hospital mortality | 1379 (12.0%) | 1290 (7.6%) | < 0.001 |
Secondary outcomes | |||
Length of hospital stay, days | 19 ± 43 | 15 ± 17 | < 0.001 |
Discharged to home | 9398 (81.8%) | 14,583 (85.5%) | < 0.001 |
Total health care cost for the admission, USD | 7686 ± 11,009 | 6715 ± 8524 | < 0.001 |
Thromboembolism | 256 (2.2%) | 313 (1.8%) | 0.02 |
Seizure | 9 (0.0%) | 8 (0.0%) | 0.29 |